Wrinkle Injections
www.wrinkleinjections.com
Friday, November 6, 2015
THE CHANGING LANDSCAPE OF BOTULINUM TOXIN DELIVERY
Revance's RT002 beats BOTOX in mid-stage study; shares up 58% premarket--
Oct 29 2015, 08:44 ET |
About:
Revance Therapeutics, ... (RVNC)
|
By:
Douglas W. House
, SA News Editor
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment